25 XP   0   0   10

Kronos Bio Inc
Buy, Hold or Sell?

Let's analyse Kronos Bio Inc together

PenkeI guess you are interested in Kronos Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Kronos Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Kronos Bio Inc

I send you an email if I find something interesting about Kronos Bio Inc.

Quick analysis of Kronos Bio Inc (30 sec.)










What can you expect buying and holding a share of Kronos Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.65
Expected worth in 1 year
$1.23
How sure are you?
11.8%

+ What do you gain per year?

Total Gains per Share
$-1.42
Return On Investment
-148.1%

For what price can you sell your share?

Current Price per Share
$0.96
Expected price per share
$0.731 - $1
How sure are you?
50%

1. Valuation of Kronos Bio Inc (5 min.)




Live pricePrice per Share (EOD)

$0.96

Intrinsic Value Per Share

$-16.68 - $-19.38

Total Value Per Share

$-14.03 - $-16.73

2. Growth of Kronos Bio Inc (5 min.)




Is Kronos Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$159m$280.3m-$88.7m-46.3%

How much money is Kronos Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$27.4m-$32.1m$4.6m17.0%
Net Profit Margin-2,010.5%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Kronos Bio Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#291 / 1010

Most Revenue
#461 / 1010

Most Profit
#762 / 1010

Most Efficient
#848 / 1010

What can you expect buying and holding a share of Kronos Bio Inc? (5 min.)

Welcome investor! Kronos Bio Inc's management wants to use your money to grow the business. In return you get a share of Kronos Bio Inc.

What can you expect buying and holding a share of Kronos Bio Inc?

First you should know what it really means to hold a share of Kronos Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Kronos Bio Inc is $0.96. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Kronos Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Kronos Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.65. Based on the TTM, the Book Value Change Per Share is $-0.36 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.42 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Kronos Bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.42-43.9%-0.47-48.8%-0.55-57.7%-0.48-49.9%-0.48-49.9%
Usd Book Value Change Per Share-0.33-33.9%-0.36-37.0%-0.42-43.6%0.1616.2%0.1616.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.33-33.9%-0.36-37.0%-0.42-43.6%0.1616.2%0.1616.2%
Usd Price Per Share1.25-1.43-3.96-8.19-8.19-
Price to Earnings Ratio-0.74--0.77--1.75--3.85--3.85-
Price-to-Total Gains Ratio-3.84--4.07--9.18--20.76--20.76-
Price to Book Ratio0.47-0.45-0.82-1.28-1.28-
Price-to-Total Gains Ratio-3.84--4.07--9.18--20.76--20.76-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.96
Number of shares1041
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.360.16
Usd Total Gains Per Share-0.360.16
Gains per Quarter (1041 shares)-369.93162.10
Gains per Year (1041 shares)-1,479.71648.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1480-14900648638
20-2959-2970012971286
30-4439-4450019451934
40-5919-5930025942582
50-7399-7410032423230
60-8878-8890038903878
70-10358-10370045394526
80-11838-11850051875174
90-13317-13330058355822
100-14797-14810064846470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%2.014.01.011.8%2.014.01.011.8%2.014.01.011.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%2.014.01.011.8%2.014.01.011.8%2.014.01.011.8%

Fundamentals of Kronos Bio Inc

About Kronos Bio Inc

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutics for various cancer and other serious diseases in the United States. The company's lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 2 clinical trial; and KB-9558, a core oncogenic transcription factor that drives multiple myeloma. Kronos Bio, Inc. was incorporated in 2017 and is headquartered in San Mateo, California.

Fundamental data was last updated by Penke on 2024-04-11 12:51:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Kronos Bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Kronos Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Kronos Bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -1,107.6% means that $-11.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Kronos Bio Inc:

  • The MRQ is -1,107.6%. The company is making a huge loss. -2
  • The TTM is -2,010.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,107.6%TTM-2,010.5%+902.9%
TTM-2,010.5%YOY--2,010.5%
TTM-2,010.5%5Y-203,558,688.1%+203,556,677.5%
5Y-203,558,688.1%10Y-203,558,688.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,107.6%-200.1%-907.5%
TTM-2,010.5%-216.8%-1,793.7%
YOY--288.3%+288.3%
5Y-203,558,688.1%-449.1%-203,558,239.0%
10Y-203,558,688.1%-605.5%-203,558,082.6%
1.1.2. Return on Assets

Shows how efficient Kronos Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Kronos Bio Inc to the Biotechnology industry mean.
  • -11.9% Return on Assets means that Kronos Bio Inc generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Kronos Bio Inc:

  • The MRQ is -11.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.9%TTM-11.1%-0.7%
TTM-11.1%YOY-9.7%-1.4%
TTM-11.1%5Y-9.4%-1.8%
5Y-9.4%10Y-9.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.9%-13.3%+1.4%
TTM-11.1%-12.8%+1.7%
YOY-9.7%-11.7%+2.0%
5Y-9.4%-13.9%+4.5%
10Y-9.4%-15.7%+6.3%
1.1.3. Return on Equity

Shows how efficient Kronos Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Kronos Bio Inc to the Biotechnology industry mean.
  • -15.9% Return on Equity means Kronos Bio Inc generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Kronos Bio Inc:

  • The MRQ is -15.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.9%TTM-14.6%-1.3%
TTM-14.6%YOY-11.5%-3.1%
TTM-14.6%5Y-9.5%-5.2%
5Y-9.5%10Y-9.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.9%-16.9%+1.0%
TTM-14.6%-16.1%+1.5%
YOY-11.5%-15.1%+3.6%
5Y-9.5%-19.3%+9.8%
10Y-9.5%-20.2%+10.7%

1.2. Operating Efficiency of Kronos Bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Kronos Bio Inc is operating .

  • Measures how much profit Kronos Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Kronos Bio Inc to the Biotechnology industry mean.
  • An Operating Margin of -1,196.2% means the company generated $-11.96  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Kronos Bio Inc:

  • The MRQ is -1,196.2%. The company is operating very inefficient. -2
  • The TTM is -2,261.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,196.2%TTM-2,261.6%+1,065.4%
TTM-2,261.6%YOY--2,261.6%
TTM-2,261.6%5Y-203,558,747.1%+203,556,485.6%
5Y-203,558,747.1%10Y-203,558,747.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,196.2%-296.2%-900.0%
TTM-2,261.6%-232.5%-2,029.1%
YOY--298.2%+298.2%
5Y-203,558,747.1%-492.1%-203,558,255.0%
10Y-203,558,747.1%-632.4%-203,558,114.7%
1.2.2. Operating Ratio

Measures how efficient Kronos Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 12.96 means that the operating costs are $12.96 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Kronos Bio Inc:

  • The MRQ is 12.962. The company is inefficient in keeping operating costs low. -1
  • The TTM is 23.894. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ12.962TTM23.894-10.932
TTM23.894YOY-+23.894
TTM23.8945Y2,039,879.861-2,039,855.968
5Y2,039,879.86110Y2,039,879.8610.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.9623.231+9.731
TTM23.8943.310+20.584
YOY-3.890-3.890
5Y2,039,879.8615.739+2,039,874.122
10Y2,039,879.8617.876+2,039,871.985

1.3. Liquidity of Kronos Bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Kronos Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.24 means the company has $7.24 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Kronos Bio Inc:

  • The MRQ is 7.239. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.514. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.239TTM8.514-1.275
TTM8.514YOY14.448-5.934
TTM8.5145Y18.122-9.607
5Y18.12210Y18.1220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.2393.890+3.349
TTM8.5144.173+4.341
YOY14.4485.344+9.104
5Y18.1226.126+11.996
10Y18.1226.448+11.674
1.3.2. Quick Ratio

Measures if Kronos Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Kronos Bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 11.41 means the company can pay off $11.41 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Kronos Bio Inc:

  • The MRQ is 11.406. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 14.431. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.406TTM14.431-3.025
TTM14.431YOY23.398-8.967
TTM14.4315Y27.105-12.674
5Y27.10510Y27.1050.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.4063.514+7.892
TTM14.4313.998+10.433
YOY23.3985.380+18.018
5Y27.1056.105+21.000
10Y27.1056.404+20.701

1.4. Solvency of Kronos Bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Kronos Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Kronos Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.25 means that Kronos Bio Inc assets are financed with 25.4% credit (debt) and the remaining percentage (100% - 25.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Kronos Bio Inc:

  • The MRQ is 0.254. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.236. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.254TTM0.236+0.018
TTM0.236YOY0.151+0.084
TTM0.2365Y0.358-0.123
5Y0.35810Y0.3580.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2540.339-0.085
TTM0.2360.336-0.100
YOY0.1510.271-0.120
5Y0.3580.366-0.008
10Y0.3580.389-0.031
1.4.2. Debt to Equity Ratio

Measures if Kronos Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Kronos Bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 34.1% means that company has $0.34 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Kronos Bio Inc:

  • The MRQ is 0.341. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.309. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.341TTM0.309+0.032
TTM0.309YOY0.179+0.130
TTM0.3095Y0.173+0.136
5Y0.17310Y0.1730.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3410.388-0.047
TTM0.3090.402-0.093
YOY0.1790.335-0.156
5Y0.1730.426-0.253
10Y0.1730.461-0.288

2. Market Valuation of Kronos Bio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Kronos Bio Inc generates.

  • Above 15 is considered overpriced but always compare Kronos Bio Inc to the Biotechnology industry mean.
  • A PE ratio of -0.74 means the investor is paying $-0.74 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Kronos Bio Inc:

  • The EOD is -0.570. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.742. Based on the earnings, the company is expensive. -2
  • The TTM is -0.767. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.570MRQ-0.742+0.172
MRQ-0.742TTM-0.767+0.026
TTM-0.767YOY-1.746+0.979
TTM-0.7675Y-3.851+3.084
5Y-3.85110Y-3.8510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.570-2.264+1.694
MRQ-0.742-2.629+1.887
TTM-0.767-2.680+1.913
YOY-1.746-4.145+2.399
5Y-3.851-6.257+2.406
10Y-3.851-6.254+2.403
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Kronos Bio Inc:

  • The EOD is -0.576. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.750. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.560. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.576MRQ-0.750+0.174
MRQ-0.750TTM-1.560+0.810
TTM-1.560YOY-2.573+1.013
TTM-1.5605Y-5.663+4.103
5Y-5.66310Y-5.6630.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.576-2.973+2.397
MRQ-0.750-3.333+2.583
TTM-1.560-3.553+1.993
YOY-2.573-5.605+3.032
5Y-5.663-8.376+2.713
10Y-5.663-8.865+3.202
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Kronos Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.47 means the investor is paying $0.47 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Kronos Bio Inc:

  • The EOD is 0.363. Based on the equity, the company is cheap. +2
  • The MRQ is 0.472. Based on the equity, the company is cheap. +2
  • The TTM is 0.452. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.363MRQ0.472-0.110
MRQ0.472TTM0.452+0.021
TTM0.452YOY0.817-0.366
TTM0.4525Y1.282-0.831
5Y1.28210Y1.2820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3631.896-1.533
MRQ0.4722.115-1.643
TTM0.4522.093-1.641
YOY0.8172.884-2.067
5Y1.2823.542-2.260
10Y1.2823.916-2.634
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Kronos Bio Inc.

3.1. Institutions holding Kronos Bio Inc

Institutions are holding 44.769% of the shares of Kronos Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Omega Fund Management LLC6.54754.5591381828300
2023-09-30Bvf Inc4.98150.10182905043915583.2543
2023-12-31Vida Ventures Advisors, LLC4.74194.1152276531400
2023-12-31Perceptive Advisors LLC3.00560.0489175274500
2023-12-31Vanguard Group Inc2.91630.00011700677123120.7292
2023-12-31PARTNERS CAPITAL INVESTMENT GROUP, LLP2.85650.0457166579700
2023-12-31Alphabet Inc2.46630.0834143823200
2023-12-31Wildcat Capital Management, LLC2.22570.561129795900
2023-12-31BlackRock Inc1.832201068504-312848-22.648
2023-12-31Renaissance Technologies Corp1.56550.0018912926-88774-8.8623
2023-12-31Millennium Management LLC1.45410.0005848000-147984-14.8581
2023-12-31Artal Group S A1.44550.035842954-700000-45.3675
2023-12-31Acadian Asset Management LLC1.13340.0032660941459967.4797
2023-12-31Geode Capital Management, LLC0.73480.0001428522182054.4368
2023-12-31HPM Partners LLC0.70440.00174107964107960
2023-09-30D. E. Shaw & Co LP0.63580.00053707678890.2403
2023-12-31FMR Inc0.626203652003605087683.4612
2023-12-31Acuitas Investments, LLC0.56240.2141327976-845-0.257
2023-12-31Choate Investment Advisors0.52930.01230869700
2023-12-31Bridgeway Capital Management, LLC0.50360.00792936753490013.4866
Total 41.46859.79224183008-275287-1.1%

3.2. Funds holding Kronos Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.19460.0001131887200
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.93110.000655954100
2024-02-29Fidelity Extended Market Index0.4070.0007244597-1185-0.4821
2023-12-31Bridgeway Ultra-Small Company0.24990.21661501753490030.2754
2023-12-31Bridgeway Ultra-Small Company Market0.23880.096514350000
2023-12-31Kennedy Micro Cap Opportunities0.17770.2594106798-2261-2.0732
2024-03-28iShares Micro-Cap ETF0.16060.01369649400
2023-09-30BlackRock Extended Mkt Composite0.13290.00077988400
2024-02-29Fidelity Total Market Index0.12860.00017728700
2024-03-31BlackRock Extended Equity Market K0.1160.000669717250.0359
2024-02-29BlackRock Advantage SMID Cap Instl0.10230.015661494-4357-6.6165
2024-02-29Fidelity Series Total Market Index0.09330.00015606000
2023-12-31Forefront Tiresias Strategy0.07571.267445468850022.9929
2024-02-29BlackRock Advantage Small Cap Core Instl0.07170.00134306500
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06190.00083717800
2023-12-31Northern Trust Extended Eq Market Idx0.06190.00083717800
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.05810.00073489000
2024-02-29Vanguard Balanced Index Inv0.05130.00013083900
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04660.000728022530.1895
2024-01-31BlackRock Advantage SMID Cap V.I. Fd I0.04540.020127270-9489-25.8141
Total 5.40541.89653248329+26186+0.8%

3.3. Insider Transactions

Insiders are holding 19.627% of the shares of Kronos Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-21Elizabeth A OlekSELL73681.05
2024-01-04Barbara KosaczSELL106761.18
2024-01-04Christopher DinsmoreSELL73661.18
2024-01-04Jorge DimartinoSELL120091.18
2023-12-12Christopher DinsmoreSELL100321.3
2023-12-12Jorge DimartinoSELL173671.3
2023-11-17Norbert W BischofbergerBUY979351.08
2023-11-15Norbert W BischofbergerBUY13706880.8
2023-07-06Christopher DinsmoreSELL66341.75
2023-07-06Jorge DimartinoSELL108181.75
2023-07-06Yasir B Al-wakeelSELL96171.75

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Kronos Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.325-0.355+9%-0.418+29%0.156-309%0.156-309%
Book Value Per Share--2.6473.189-17%4.665-43%3.846-31%3.846-31%
Current Ratio--7.2398.514-15%14.448-50%18.122-60%18.122-60%
Debt To Asset Ratio--0.2540.236+8%0.151+68%0.358-29%0.358-29%
Debt To Equity Ratio--0.3410.309+10%0.179+91%0.173+97%0.173+97%
Dividend Per Share----0%-0%-0%-0%
Eps---0.421-0.469+11%-0.554+32%-0.479+14%-0.479+14%
Free Cash Flow Per Share---0.417-0.330-21%-0.381-9%-0.339-19%-0.339-19%
Free Cash Flow To Equity Per Share---0.414-0.326-21%-0.377-9%0.074-657%0.074-657%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---19.378--------
Intrinsic Value_10Y_min---16.676--------
Intrinsic Value_1Y_max---1.673--------
Intrinsic Value_1Y_min---1.643--------
Intrinsic Value_3Y_max---5.232--------
Intrinsic Value_3Y_min---4.991--------
Intrinsic Value_5Y_max---9.038--------
Intrinsic Value_5Y_min---8.371--------
Market Cap57691200.000-30%75118750.00086086087.500-13%237976200.000-68%492107350.000-85%492107350.000-85%
Net Profit Margin---11.076-20.105+82%--100%-2035586.881+18378066%-2035586.881+18378066%
Operating Margin---11.962-22.616+89%--100%-2035587.471+17017721%-2035587.471+17017721%
Operating Ratio--12.96223.894-46%-+100%2039879.861-100%2039879.861-100%
Pb Ratio0.363-30%0.4720.452+5%0.817-42%1.282-63%1.282-63%
Pe Ratio-0.570+23%-0.742-0.767+3%-1.746+135%-3.851+419%-3.851+419%
Price Per Share0.960-30%1.2501.433-13%3.960-68%8.189-85%8.189-85%
Price To Free Cash Flow Ratio-0.576+23%-0.750-1.560+108%-2.573+243%-5.663+656%-5.663+656%
Price To Total Gains Ratio-2.952+23%-3.844-4.073+6%-9.175+139%-20.762+440%-20.762+440%
Quick Ratio--11.40614.431-21%23.398-51%27.105-58%27.105-58%
Return On Assets---0.119-0.111-6%-0.097-18%-0.094-21%-0.094-21%
Return On Equity---0.159-0.146-8%-0.115-28%-0.095-41%-0.095-41%
Total Gains Per Share---0.325-0.355+9%-0.418+29%0.156-309%0.156-309%
Usd Book Value--159078000.000191661250.000-17%280362250.000-43%231137470.588-31%231137470.588-31%
Usd Book Value Change Per Share---0.325-0.355+9%-0.418+29%0.156-309%0.156-309%
Usd Book Value Per Share--2.6473.189-17%4.665-43%3.846-31%3.846-31%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.421-0.469+11%-0.554+32%-0.479+14%-0.479+14%
Usd Free Cash Flow---25055000.000-19815250.000-21%-22875750.000-9%-20353352.941-19%-20353352.941-19%
Usd Free Cash Flow Per Share---0.417-0.330-21%-0.381-9%-0.339-19%-0.339-19%
Usd Free Cash Flow To Equity Per Share---0.414-0.326-21%-0.377-9%0.074-657%0.074-657%
Usd Market Cap57691200.000-30%75118750.00086086087.500-13%237976200.000-68%492107350.000-85%492107350.000-85%
Usd Price Per Share0.960-30%1.2501.433-13%3.960-68%8.189-85%8.189-85%
Usd Profit---25320000.000-27462250.000+8%-32141000.000+27%-28435294.118+12%-28435294.118+12%
Usd Revenue--2286000.0001572000.000+45%-+100%369884.118+518%369884.118+518%
Usd Total Gains Per Share---0.325-0.355+9%-0.418+29%0.156-309%0.156-309%
 EOD+3 -5MRQTTM+13 -20YOY+11 -225Y+11 -2210Y+11 -22

4.2. Fundamental Score

Let's check the fundamental score of Kronos Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.570
Price to Book Ratio (EOD)Between0-10.363
Net Profit Margin (MRQ)Greater than0-11.076
Operating Margin (MRQ)Greater than0-11.962
Quick Ratio (MRQ)Greater than111.406
Current Ratio (MRQ)Greater than17.239
Debt to Asset Ratio (MRQ)Less than10.254
Debt to Equity Ratio (MRQ)Less than10.341
Return on Equity (MRQ)Greater than0.15-0.159
Return on Assets (MRQ)Greater than0.05-0.119
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Kronos Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.422
Ma 20Greater thanMa 501.139
Ma 50Greater thanMa 1001.141
Ma 100Greater thanMa 2001.167
OpenGreater thanClose0.960
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -792432-360-109-469214-25527419



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets213,279
Total Liabilities54,201
Total Stockholder Equity159,078
 As reported
Total Liabilities 54,201
Total Stockholder Equity+ 159,078
Total Assets = 213,279

Assets

Total Assets213,279
Total Current Assets178,778
Long-term Assets34,501
Total Current Assets
Cash And Cash Equivalents 64,326
Short-term Investments 108,671
Other Current Assets 5,781
Total Current Assets  (as reported)178,778
Total Current Assets  (calculated)178,778
+/- 0
Long-term Assets
Property Plant Equipment 29,909
Long Term Investments 1,989
Long-term Assets Other 577
Long-term Assets  (as reported)34,501
Long-term Assets  (calculated)32,475
+/- 2,026

Liabilities & Shareholders' Equity

Total Current Liabilities24,695
Long-term Liabilities29,506
Total Stockholder Equity159,078
Total Current Liabilities
Short-term Debt 2,893
Accounts payable 883
Other Current Liabilities 11,335
Total Current Liabilities  (as reported)24,695
Total Current Liabilities  (calculated)15,111
+/- 9,584
Long-term Liabilities
Capital Lease Obligations 28,272
Long-term Liabilities  (as reported)29,506
Long-term Liabilities  (calculated)28,272
+/- 1,234
Total Stockholder Equity
Common Stock59
Retained Earnings -508,861
Accumulated Other Comprehensive Income 19
Other Stockholders Equity 667,861
Total Stockholder Equity (as reported)159,078
Total Stockholder Equity (calculated)159,078
+/-0
Other
Capital Stock59
Cash and Short Term Investments 172,997
Common Stock Shares Outstanding 58,268
Current Deferred Revenue9,584
Liabilities and Stockholders Equity 213,279
Net Debt -36,054
Net Invested Capital 159,078
Net Working Capital 154,083
Property Plant and Equipment Gross 37,199
Short Long Term Debt Total 28,272



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
0
102,686
0
120,534
262,556
511,964
487,961
471,742
447,529
391,476
365,856
341,220
317,668
294,938
289,025
260,615
237,993
213,279
213,279237,993260,615289,025294,938317,668341,220365,856391,476447,529471,742487,961511,964262,556120,5340102,6860
   > Total Current Assets 
93,303
93,303
82,540
82,540
212,893
419,802
405,271
424,303
402,827
347,554
310,591
274,774
264,630
244,291
232,268
224,122
191,563
178,778
178,778191,563224,122232,268244,291264,630274,774310,591347,554402,827424,303405,271419,802212,89382,54082,54093,30393,303
       Cash And Cash Equivalents 
0
32,570
0
37,966
156,196
462,062
141,448
185,658
216,993
339,509
148,979
86,140
270,341
75,973
61,646
44,396
57,599
64,326
64,32657,59944,39661,64675,973270,34186,140148,979339,509216,993185,658141,448462,062156,19637,966032,5700
       Short-term Investments 
0
59,614
0
43,497
55,069
165,052
257,476
231,219
181,389
141,239
154,157
181,749
190,774
162,212
164,756
175,064
129,114
108,671
108,671129,114175,064164,756162,212190,774181,749154,157141,239181,389231,219257,476165,05255,06943,497059,6140
       Net Receivables 
198
198
174
174
217
612
1,274
1,224
1,048
816
661
544
607
572
516
343
492
0
04923435165726075446618161,0481,2241,274612217174174198198
       Other Current Assets 
371
921
738
903
1,411
6,741
5,073
6,202
3,397
7,229
6,794
6,341
5,768
6,106
5,866
4,662
4,850
5,781
5,7814,8504,6625,8666,1065,7686,3416,7947,2293,3976,2025,0736,7411,411903738921371
   > Long-term Assets 
0
9,383
0
37,994
49,663
92,162
82,690
47,439
44,702
43,922
55,265
66,446
53,038
50,647
56,757
36,493
46,430
34,501
34,50146,43036,49356,75750,64753,03866,44655,26543,92244,70247,43982,69092,16249,66337,99409,3830
       Property Plant Equipment 
4,194
4,194
35,269
35,269
39,656
40,968
38,866
42,924
42,564
41,784
40,880
39,815
38,814
37,692
36,652
33,056
31,764
29,909
29,90931,76433,05636,65237,69238,81439,81540,88041,78442,56442,92438,86640,96839,65635,26935,2694,1944,194
       Long Term Investments 
0
4,762
0
0
4,774
49,001
41,684
2,377
0
0
12,246
24,493
12,086
9,762
14,885
244
11,670
1,989
1,98911,67024414,8859,76212,08624,49312,246002,37741,68449,0014,774004,7620
       Long-term Assets Other 
0
427
0
2,725
5,233
2,193
2,140
2,138
2,138
2,138
2,139
2,138
2,138
3,193
5,220
3,193
2,996
577
5772,9963,1935,2203,1932,1382,1382,1392,1382,1382,1382,1402,1935,2332,72504270
> Total Liabilities 
0
125,889
0
35,608
338,836
46,445
42,704
47,635
48,506
46,379
48,836
48,977
49,981
50,439
63,420
57,273
59,373
54,201
54,20159,37357,27363,42050,43949,98148,97748,83646,37948,50647,63542,70446,445338,83635,6080125,8890
   > Total Current Liabilities 
2,697
2,697
6,187
6,187
183,604
12,856
11,285
13,078
14,774
13,626
17,078
18,230
20,105
21,486
25,264
22,055
25,672
24,695
24,69525,67222,05525,26421,48620,10518,23017,07813,62614,77413,07811,28512,856183,6046,1876,1872,6972,697
       Short-term Debt 
0
317
0
2,188
175,258
942
822
1,133
1,728
2,109
2,502
2,704
2,239
2,347
3,032
3,038
3,263
2,893
2,8933,2633,0383,0322,3472,2392,7042,5022,1091,7281,133822942175,2582,18803170
       Short Long Term Debt 
0
0
0
0
173,944
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000173,9440000
       Accounts payable 
1,506
1,506
2,465
2,465
4,443
4,550
3,586
3,342
3,940
998
4,719
3,289
1,462
5,047
6,039
2,676
4,082
883
8834,0822,6766,0395,0471,4623,2894,7199983,9403,3423,5864,5504,4432,4652,4651,5061,506
       Other Current Liabilities 
56
56
691
691
2,123
2,390
2,602
2,087
1,756
1,456
9,857
12,237
16,404
14,092
7,538
7,517
9,750
11,335
11,3359,7507,5177,53814,09216,40412,2379,8571,4561,7562,0872,6022,3902,1236916915656
   > Long-term Liabilities 
0
123,192
0
29,421
155,232
33,589
31,419
34,557
33,732
32,753
31,758
30,747
29,876
28,953
38,156
35,218
33,701
29,506
29,50633,70135,21838,15628,95329,87630,74731,75832,75333,73234,55731,41933,589155,23229,4210123,1920
       Capital Lease Obligations Min Short Term Debt
0
211
0
28,509
-144,460
31,120
29,394
32,843
32,326
31,653
30,963
30,257
29,526
28,744
27,945
27,126
26,279
25,379
25,37926,27927,12627,94528,74429,52630,25730,96331,65332,32632,84329,39431,120-144,46028,50902110
       Long-term Liabilities Other 
0
74
0
912
2,841
2,469
2,025
1,714
1,406
1,100
795
490
350
209
10,211
8,092
0
0
008,09210,2112093504907951,1001,4061,7142,0252,4692,8419120740
> Total Stockholder Equity
0
-23,203
0
84,926
-76,280
465,519
445,257
424,107
399,023
345,097
317,020
292,243
267,687
244,499
225,605
203,342
178,620
159,078
159,078178,620203,342225,605244,499267,687292,243317,020345,097399,023424,107445,257465,519-76,28084,9260-23,2030
   Common Stock
6
6
6
29
6
54
54
55
55
56
56
56
56
57
57
58
58
59
59585857575656565655555454629666
   Retained Earnings Total Equity00-452,167-422,426-396,188-364,406-332,150-299,247-262,984-200,650-167,047-137,992-111,90600000
   Accumulated Other Comprehensive Income 
0
-18
0
164
47
-19
-23
6
7
-39
-170
-661
-1,050
-792
-360
-469
-255
19
19-255-469-360-792-1,050-661-170-3976-23-19471640-180
   Capital Surplus 
0
0
0
0
0
577,390
583,218
591,093
599,611
608,064
616,381
624,998
633,087
641,422
648,334
655,920
0
0
00655,920648,334641,422633,087624,998616,381608,064599,611591,093583,218577,39000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
-18
271
164
123,769
-120,491
465,484
95,257
119,351
152,082
608,064
616,381
624,998
633,087
641,422
648,334
655,920
662,358
667,861
667,861662,358655,920648,334641,422633,087624,998616,381608,064152,082119,35195,257465,484-120,491123,769164271-18



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,288
Cost of Revenue-4,916
Gross Profit1,3721,372
 
Operating Income (+$)
Gross Profit1,372
Operating Expense-120,302
Operating Income-118,930-118,930
 
Operating Expense (+$)
Research Development82,343
Selling General Administrative41,739
Selling And Marketing Expenses3,780
Operating Expense120,302127,862
 
Net Interest Income (+$)
Interest Income9,033
Interest Expense-9,157
Other Finance Cost-9,157
Net Interest Income9,033
 
Pretax Income (+$)
Operating Income-118,930
Net Interest Income9,033
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-112,673-125,187
EBIT - interestExpense = -128,087
-112,673
-103,516
Interest Expense9,157
Earnings Before Interest and Taxes (EBIT)-118,930-103,516
Earnings Before Interest and Taxes (EBITDA)-114,014
 
After tax Income (+$)
Income Before Tax-112,673
Tax Provision-0
Net Income From Continuing Ops-119,135-112,673
Net Income-112,673
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses125,218
Total Other Income/Expenses Net6,257-9,033
 

Technical Analysis of Kronos Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Kronos Bio Inc. The general trend of Kronos Bio Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Kronos Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Kronos Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1 < 1 < 1.

The bearish price targets are: 0.731.

Tweet this
Kronos Bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Kronos Bio Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Kronos Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Kronos Bio Inc. The current macd is -0.05781398.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Kronos Bio Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Kronos Bio Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Kronos Bio Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Kronos Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartKronos Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Kronos Bio Inc. The current adx is 19.97.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Kronos Bio Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Kronos Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Kronos Bio Inc. The current sar is 1.13828166.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Kronos Bio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Kronos Bio Inc. The current rsi is 33.42. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Kronos Bio Inc Daily Relative Strength Index (RSI) ChartKronos Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Kronos Bio Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Kronos Bio Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Kronos Bio Inc Daily Stochastic Oscillator ChartKronos Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Kronos Bio Inc. The current cci is -123.93593587.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Kronos Bio Inc Daily Commodity Channel Index (CCI) ChartKronos Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Kronos Bio Inc. The current cmo is -49.58346632.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Kronos Bio Inc Daily Chande Momentum Oscillator (CMO) ChartKronos Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Kronos Bio Inc. The current willr is -83.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Kronos Bio Inc Daily Williams %R ChartKronos Bio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Kronos Bio Inc.

Kronos Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Kronos Bio Inc. The current atr is 0.09256709.

Kronos Bio Inc Daily Average True Range (ATR) ChartKronos Bio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Kronos Bio Inc. The current obv is 3,512,747.

Kronos Bio Inc Daily On-Balance Volume (OBV) ChartKronos Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Kronos Bio Inc. The current mfi is 17.89.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Kronos Bio Inc Daily Money Flow Index (MFI) ChartKronos Bio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Kronos Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Kronos Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Kronos Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.422
Ma 20Greater thanMa 501.139
Ma 50Greater thanMa 1001.141
Ma 100Greater thanMa 2001.167
OpenGreater thanClose0.960
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Kronos Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Kronos Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Kronos Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Kronos Bio Inc

I send you an email if I find something interesting about Kronos Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Kronos Bio Inc.

Receive notifications about Kronos Bio Inc in your mailbox!